4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001593968-23-000643
Chief Technical Officer acquired 186,219 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
MOORE TIMOTHY L. · Chief Technical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-24 | Grant or award : show line 1 in the form | +186,219 | 186,219 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-24 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +831,024 | 831,024 | D |
Loading xslF345X04/primary_01.xml…